Jessica J. Federer's most recent trade in Sage Therapeutics Inc was a trade of 21,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Jessica J. Federer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jessica J. Federer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | J. Jessica Federer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 3,177 | 3,177 | - | - | Stock Options (Right to buy) | |
| Sage Therapeutics Inc | Jessica J. Federer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jessica J. Federer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 19,894 | 19,894 | - | - | Stock Options (Right to buy) |